Similarly, in the current study, more than 50% of the SLE patients presented low SLEDAI scores, which could have resulted in the lack of significant difference regarding VEGF concentrations between the total patient group and the controls. The gene discussed is VEGFA; the disease is systemic lupus erythematosus.